Pirfenidone

This classification denotes a radioprotective agent and nonsteroidal antiinflammatory drug with the molecular formula C12H11NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) D7NLD2JX7U, chemically known as 2(1h)-pyridone, 5-methyl-1-phenyl- but more generally known as pirfenidone, which bears US NIH Compound Identifier 40632. European Medicines Agency schedules Pirfenidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09907MIG. The term PIRFENIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). PIRFENIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pirfenidone under HS 29337900 and SITC 51561. As of Q4 2014, PIRFENIDONE remains US FDA's Preferred Term for this commodity. Pirfenidone bears US NLM identifiers UMLS ID C0298067 and NCI Concept Code C2635. SMILES: CC1=CN(C(=O)C=C1)C2=CC=CC=C2.